Efficacity, Safety and Cost of Intravenous Morphine Titration Alone or Combined to Ketamine

Brief Summary

This is a randomised, controlled, double blinded study comparing in the postoperative setting the analgesic efficacy, the safety and the cost in two groups of patients receiving in the postanesthesia care unit either intravenous morphine titration alone or intravenous morphine titration combined to ketamine.

Intervention / Treatment

  • Ketamine (DRUG)
    intravenous morphine titration combined to ketamine

Condition or Disease

  • Postoperative Pain

Phase

Study Design

Study type: INTERVENTIONAL
Status: Completed
Study results: No Results Available
Age: 18 Years to 75 Years
Enrollment: 160 (ACTUAL)
Funded by: Other
Allocation: Randomized
Primary Purpose: Treatment

Masking

Clinical Trial Dates

Start date: May 01, 2003
Primary Completion: Jan 01, 2009 ACTUAL
Completion Date: Jan 01, 2009 ACTUAL
Study First Posted: Jun 17, 2010 ESTIMATED
Results First Posted: Aug 31, 2020
Last Updated: Jun 16, 2010

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Randomised, controlled, double blinded study comparing in the postoperative setting the analgesic efficacy, the safety and the cost in two groups of patients receiving in the postanesthesia care unit either intravenous morphine titration alone or intravenous morphine titration combined to ketamine

Eligibility Criteria

Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: Yes

Inclusion Criteria:

* Age \> 18 yrs
* scheduled surgery
* General anesthesia
* ASA I to III
* Able to use a VAS
* No psychological disorders, able to speak french

Exclusion Criteria:

* Age \< 18 yrs
* Locoregional anesthesia or analgesia
* Allergia to morphine or ketamine
* Morphine or ketamine contraindication
* Pregnancy or breast-feeding

Primary Outcomes
  • the analgesic efficacy, in two groups of patients recevieving in the postanesthesia care unit either intravenous morphine titration alone or intravenous morphine titration combined to ketamine

More Details

NCT Number: NCT01146145
Acronym: KEMO
Other IDs: P020401
Study URL: https://clinicaltrials.gov/study/NCT01146145
Last updated: Sep 29, 2023